Table 2

Complications

All patients (n=1134)MACCE (n=124)Bleeding complications (n=108)
Cardiovascular complications, n (%)
 Stroke1 (0.8)
 Pulmonary oedema20 (16.1)
 Cardiogenic shock14 (11.3)
 Significant arrhythmia16 (12.9)
 Acute limb ischaemia2 (1.6)
 Myocardial infarction71 (57.2)
 ST17 (13.7)
  Definite10
  Probable3
  Possible4
 Time to ST (days)2 (0–8)
 Death (associated with ST)5 (29.4)
Bleeding complications, n (%)
 Site
  Surgical92 (85.2)
  Gastrointestinal7
  Retroperitoneal1
  Other3
 Repeat surgery to treat bleeding20 (18.5)
 Transfusion, n (%)143 (12.6)33 (26.6)84 (77.8)
  Erythrocytes33 (26.6)84 (100)
  Plasma5 (4)9 (8.3)
  Platelets5 (4)9 (8.3)
 Major bleeding complications92 (85.2)
Timing of complication
 After procedure (%)10084
 Time after surgery (days)3.3±3.95.3±5.3
Death rate, n (%) (95% CI)25 (2.2) (1.4 to 3.2)18 (14.5) (8.8 to 22.0)13 (12) (6.6 to 19.7)
  • MACCE, major adverse cardiac and cerebrovascular events; ST, stent thrombosis.